Efficacy and safety of half-dose desmopressin for bleeding prophylaxis in bleeding disorder patients undergoing predominantly low to moderate risk invasive procedures.
Fateeha FurqanRonald ShamPeter KouidesPublished in: American journal of hematology (2020)